{
  "responseHeader":{
    "status":0,
    "QTime":0,
    "params":{
      "q":"iati_identifier:GB-GOV-1-400499",
      "fl":"*",
      "format":"json"
    }
  },
  "response":{
    "numFound":1,
    "start":0,
    "numFoundExact":true,
    "docs":[{
      "lang":"en",
      "default_lang":"en",
      "default-currency":"GBP",
      "default_currency":"GBP",
      "hierarchy":1,
      "iati-identifier":"GB-GOV-1-400499",
      "iati_identifier":"GB-GOV-1-400499",
      "reporting-org.ref":"GB-GOV-1",
      "reporting_org_ref":"GB-GOV-1",
      "reporting-org.type":"10",
      "reporting_org_type_code":"10",
      "reporting-org.narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"],
      "reporting_org_narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"],
      "reporting-org.narrative.lang":[" "],
      "title.narrative":["Support to Product Development Partnerships on Global Health - 2024-2028."],
      "title_narrative":["Support to Product Development Partnerships on Global Health - 2024-2028."],
      "title_narrative_text":["Support to Product Development Partnerships on Global Health - 2024-2028."],
      "title.narrative.lang":[" "],
      "title_narrative_lang":[" "],
      "description.type":["1"],
      "description_type":["1"],
      "description.narrative":["Support to Product Development Partnerships through new and existing partnerships, drawing on UK and global science expertise, bringing to market vaccines, contraceptives, medicines and other tools."],
      "description_narrative":["Support to Product Development Partnerships through new and existing partnerships, drawing on UK and global science expertise, bringing to market vaccines, contraceptives, medicines and other tools."],
      "description_narrative_text":["Support to Product Development Partnerships through new and existing partnerships, drawing on UK and global science expertise, bringing to market vaccines, contraceptives, medicines and other tools."],
      "description.narrative.lang":[" "],
      "description_narrative_lang":[" "],
      "participating-org.ref":["GB-GOV-1","GB-GOV-1","1014984","CH-FDJP-CHE110141200","GB-CHC-222655","Not available","Not available","Not available","US-EIN-91-1157127"],
      "participating_org_ref":["GB-GOV-1","GB-GOV-1","1014984","CH-FDJP-CHE110141200","GB-CHC-222655","Not available","Not available","Not available","US-EIN-91-1157127"],
      "participating-org.type":["10","10"],
      "participating_org_type":["10","10"],
      "participating-org.role":["1","2","4","4","4","4","4","4","4","4"],
      "participating_org_role":["1","2","4","4","4","4","4","4","4","4"],
      "participating-org.narrative":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","KINGS COLLEGE LONDON","WORLD MOSQUITO PROGRAM LTD","Drugs for Neglected Diseases Initiative","Liverpool School of Tropical Medicine","Innovative Vector Control Consortium","TB Alliance","Medicines for Malaria Venture","Path"],
      "participating_org_narrative":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","KINGS COLLEGE LONDON","WORLD MOSQUITO PROGRAM LTD","Drugs for Neglected Diseases Initiative","Liverpool School of Tropical Medicine","Innovative Vector Control Consortium","TB Alliance","Medicines for Malaria Venture","Path"],
      "participating_org_narrative_text":["Foreign, Commonwealth and Development Office (FCDO)","Foreign, Commonwealth and Development Office (FCDO)","KINGS COLLEGE LONDON","WORLD MOSQUITO PROGRAM LTD","Drugs for Neglected Diseases Initiative","Liverpool School of Tropical Medicine","Innovative Vector Control Consortium","TB Alliance","Medicines for Malaria Venture","Path"],
      "participating-org.narrative.lang":[" "," "," "," "," "," "," "," "," "," "],
      "participating_org_narrative_lang":[" "," "," "," "," "," "," "," "," "," "],
      "activity-status.code":"2",
      "activity_status_code":"2",
      "activity-date.type":["1","2","3"],
      "activity_date_type":["1","2","3"],
      "activity-date.iso-date":["2024-10-21T00:00:00Z","2024-11-11T00:00:00Z","2028-03-31T00:00:00Z"],
      "activity_date_iso_date":["2024-10-21T00:00:00Z","2024-11-11T00:00:00Z","2028-03-31T00:00:00Z"],
      "contact-info.type":["1"],
      "contact_info_type":["1"],
      "contact-info.organisation.narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"],
      "contact_info_organisation_narrative":["UK - Foreign, Commonwealth Development Office (FCDO)"],
      "contact_info_organisation_narrative_text":["UK - Foreign, Commonwealth Development Office (FCDO)"],
      "contact-info.organisation.narrative.lang":[" "],
      "contact_info_organisation_narrative_lang":[" "],
      "contact-info.telephone":["+44 (0) 1355 84 3132"],
      "contact_info_telephone":["+44 (0) 1355 84 3132"],
      "contact-info.email":["enquiry@fcdo.gov.uk"],
      "contact_info_email":["enquiry@fcdo.gov.uk"],
      "contact-info.mailing-address.narrative":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"],
      "contact_info_mailing_address_narrative":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"],
      "contact_info_mailing_address_narrative_text":["Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA"],
      "contact-info.mailing-address.narrative.lang":[" "],
      "contact_info_mailing_address_narrative_lang":[" "],
      "activity-scope.code":"3",
      "activity_scope_code":"3",
      "recipient-region.code":["998"],
      "recipient_region_code":["998"],
      "recipient-region.percentage":[100.0],
      "recipient_region_percentage":[100.0],
      "sector.vocabulary":["1"],
      "sector_vocabulary":["1"],
      "sector.vocabulary-uri":["http://reference.iatistandard.org/codelists/Sector/"],
      "sector_vocabulary_uri":["http://reference.iatistandard.org/codelists/Sector/"],
      "sector.code":["12182"],
      "sector_code":["12182"],
      "sector.percentage":[100.0],
      "sector_percentage":[100.0],
      "sector.narrative":["Medical research"],
      "sector_narrative":["Medical research"],
      "sector_narrative_text":["Medical research"],
      "sector.narrative.lang":[" "],
      "sector_narrative_lang":[" "],
      "policy-marker.vocabulary":["1","1","1","1","1","1"],
      "policy_marker_vocabulary":["1","1","1","1","1","1"],
      "policy-marker.code":["1","5","6","7","8","11"],
      "policy_marker_code":["1","5","6","7","8","11"],
      "policy-marker.significance":["1","0","0","0","0","0"],
      "policy_marker_significance":["1","0","0","0","0","0"],
      "policy-marker.narrative":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"],
      "policy_marker_narrative":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"],
      "policy_marker_narrative_text":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"],
      "policy-marker.narrative.lang":[" "," "," "," "," "," "],
      "policy_marker_narrative_lang":[" "," "," "," "," "," "],
      "default-tied-status.code":"5",
      "default_tied_status_code":"5",
      "related-activity.ref":["GB-GOV-1-400499-401","GB-GOV-1-400499-402","GB-GOV-1-400499-403","GB-GOV-1-400499-404","GB-GOV-1-400499-405","GB-GOV-1-400499-406","GB-GOV-1-400499-407","GB-GOV-1-400499-408","GB-GOV-1-400499-409","GB-GOV-1-400499-410"],
      "related_activity_ref":["GB-GOV-1-400499-401","GB-GOV-1-400499-402","GB-GOV-1-400499-403","GB-GOV-1-400499-404","GB-GOV-1-400499-405","GB-GOV-1-400499-406","GB-GOV-1-400499-407","GB-GOV-1-400499-408","GB-GOV-1-400499-409","GB-GOV-1-400499-410"],
      "related-activity.type":["2","2","2","2","2","2","2","2","2","2"],
      "related_activity_type":["2","2","2","2","2","2","2","2","2","2"],
      "reporting-org.type.name":"Government",
      "reporting_org_type_name":"Government",
      "recipient-region.name":["Developing countries, unspecified"],
      "recipient_region_name":["Developing countries, unspecified"],
      "policy-marker.name":["Gender Equality","Aid Targeting the Objectives of the Convention on Biological Diversity","Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation","Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation","Aid Targeting the Objectives of the Convention to Combat Desertification","Disability"],
      "policy-marker.significance.name":["significant objective","not targeted","not targeted","not targeted","not targeted","not targeted"],
      "policy-marker.vocabulary.name":["OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS","OECD DAC CRS"],
      "title.narrative.first":"Support to Product Development Partnerships on Global Health - 2024-2028.",
      "title_narrative_first":"Support to Product Development Partnerships on Global Health - 2024-2028.",
      "activity-date.start-planned":"2024-10-21T00:00:00Z",
      "activity_date_start_planned":"Mon Oct 21 00:00:00 UTC 2024",
      "activity_date_start_planned_f":"2024-10-21T00:00:00Z",
      "activity-date.common.start":"2024-11-11T00:00:00Z",
      "activity_date_start_common":"Mon Nov 11 00:00:00 UTC 2024",
      "activity_date_start_common_f":"2024-11-11T00:00:00Z",
      "activity-date.start-actual":"2024-11-11T00:00:00Z",
      "activity_date_start_actual":"Mon Nov 11 00:00:00 UTC 2024",
      "activity_date_start_actual_f":"2024-11-11T00:00:00Z",
      "activity-date.end-planned":"2028-03-31T00:00:00Z",
      "activity_date_end_planned":"Fri Mar 31 00:00:00 UTC 2028",
      "activity_date_end_planned_f":"2028-03-31T00:00:00Z",
      "activity-date.common.end":"2028-03-31T00:00:00Z",
      "activity_date_end_common":"Fri Mar 31 00:00:00 UTC 2028",
      "activity_date_end_common_f":"2028-03-31T00:00:00Z",
      "activity-status.text":"Implementation",
      "activity_status_text":"Implementation",
      "policy-marker.combined":["1__1","5__0","6__0","7__0","8__0","11__0"],
      "policy_marker_combined":["1__1","5__0","6__0","7__0","8__0","11__0"],
      "dataset.id":"1519aaf7-c22e-4dad-883b-0360dc48d320",
      "dataset_iati_id":"1519aaf7-c22e-4dad-883b-0360dc48d320",
      "dataset.name":"fcdo-set-20",
      "dataset_name":"fcdo-set-20",
      "dataset.extras.iati_version":"2.03",
      "dataset.resources.hash":"1d0b9ea390a2a3767ddb55c3b2494cda7193e063",
      "dataset.resources.url":"http://iati.fcdo.gov.uk/iati_files/solr/FCDO-set-20.xml",
      "activity-date.quarter":[4,4,1],
      "child-aggregation.budget.value":1.36113265E8,
      "child_aggregation_budget_value":1.36113265E8,
      "activity-plus-child-aggregation.budget.value":1.36113265E8,
      "activity_plus_child_aggregation_budget_value":1.36113265E8,
      "child-aggregation.budget.currency":"USD",
      "child_aggregation_budget_currency":"USD",
      "activity-plus-child-aggregation.budget.currency":"USD",
      "activity_plus_child_aggregation_budget_currency":"USD",
      "child-aggregation.budget.value-usd":1.7492075378393137E8,
      "child_aggregation_budget_value_usd":1.7492075378393137E8,
      "activity-plus-child-aggregation.budget.value-usd":1.7492075378393137E8,
      "activity_plus_child_aggregation_budget_value_usd":1.7492075378393137E8,
      "child-aggregation.budget.value-gbp":1.36113265E8,
      "child_aggregation_budget_value_gbp":1.36113265E8,
      "activity-plus-child-aggregation.budget.value-gbp":1.36113265E8,
      "activity_plus_child_aggregation_budget_value_gbp":1.36113265E8,
      "child-aggregation.outgoing-commitment.value":1.37412516E8,
      "child_aggregation_commitment_value":1.37412516E8,
      "activity-plus-child-aggregation.outgoing-commitment.value":1.37412516E8,
      "activity_plus_child_aggregation_commitment_value":1.37412516E8,
      "child-aggregation.outgoing-commitment.currency":"USD",
      "child_aggregation_commitment_currency":"USD",
      "activity-plus-child-aggregation.outgoing-commitment.currency":"USD",
      "activity_plus_child_aggregation_commitment_currency":"USD",
      "child-aggregation.outgoing-commitment.value-usd":1.7680752384520355E8,
      "child_aggregation_commitment_value_usd":1.7680752384520355E8,
      "activity-plus-child-aggregation.outgoing-commitment.value-usd":1.7680752384520355E8,
      "activity_plus_child_aggregation_commitment_value_usd":1.7680752384520355E8,
      "child-aggregation.outgoing-commitment.value-gbp":1.37412516E8,
      "child_aggregation_commitment_value_gbp":1.37412516E8,
      "activity-plus-child-aggregation.outgoing-commitment.value-gbp":1.37412516E8,
      "activity_plus_child_aggregation_commitment_value_gbp":1.37412516E8,
      "child-aggregation.disbursement.value":7.9144956E7,
      "child_aggregation_disbursement_value":7.9144956E7,
      "activity-plus-child-aggregation.disbursement.value":7.9144956E7,
      "activity_plus_child_aggregation_disbursement_value":7.9144956E7,
      "child-aggregation.disbursement.currency":"USD",
      "child_aggregation_disbursement_currency":"USD",
      "activity-plus-child-aggregation.disbursement.currency":"USD",
      "activity_plus_child_aggregation_disbursement_currency":"USD",
      "child-aggregation.disbursement.value-usd":1.0207589167271644E8,
      "child_aggregation_disbursement_value_usd":1.0207589167271644E8,
      "activity-plus-child-aggregation.disbursement.value-usd":1.0207589167271644E8,
      "activity_plus_child_aggregation_disbursement_value_usd":1.0207589167271644E8,
      "child-aggregation.disbursement.value-gbp":7.9144956E7,
      "child_aggregation_disbursement_value_gbp":7.9144956E7,
      "activity-plus-child-aggregation.disbursement.value-gbp":7.9144956E7,
      "activity_plus_child_aggregation_disbursement_value_gbp":7.9144956E7,
      "json.reporting-org":"{\"ref\": \"GB-GOV-1\", \"type\": 10, \"narrative\": \"UK - Foreign, Commonwealth Development Office (FCDO)\", \"narrative.lang\": \" \"}",
      "json.title":"{\"narrative\": \"Support to Product Development Partnerships on Global Health - 2024-2028.\", \"narrative.lang\": \" \"}",
      "json.description":["{\"type\": 1, \"narrative\": \"Support to Product Development Partnerships through new and existing partnerships, drawing on UK and global science expertise, bringing to market vaccines, contraceptives, medicines and other tools.\", \"narrative.lang\": \" \"}"],
      "json.participating-org":["{\"ref\": \"GB-GOV-1\", \"type\": 10, \"role\": 1, \"narrative\": \"Foreign, Commonwealth and Development Office (FCDO)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-1\", \"type\": 10, \"role\": 2, \"narrative\": \"Foreign, Commonwealth and Development Office (FCDO)\", \"narrative.lang\": \" \"}","{\"role\": 4, \"narrative\": \"KINGS COLLEGE LONDON\", \"narrative.lang\": \" \"}","{\"ref\": 1014984, \"role\": 4, \"narrative\": \"WORLD MOSQUITO PROGRAM LTD\", \"narrative.lang\": \" \"}","{\"ref\": \"CH-FDJP-CHE110141200\", \"role\": 4, \"narrative\": \"Drugs for Neglected Diseases Initiative\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-CHC-222655\", \"role\": 4, \"narrative\": \"Liverpool School of Tropical Medicine\", \"narrative.lang\": \" \"}","{\"ref\": \"Not available\", \"role\": 4, \"narrative\": \"Innovative Vector Control Consortium\", \"narrative.lang\": \" \"}","{\"ref\": \"Not available\", \"role\": 4, \"narrative\": \"TB Alliance\", \"narrative.lang\": \" \"}","{\"ref\": \"Not available\", \"role\": 4, \"narrative\": \"Medicines for Malaria Venture\", \"narrative.lang\": \" \"}","{\"ref\": \"US-EIN-91-1157127\", \"role\": 4, \"narrative\": \"Path\", \"narrative.lang\": \" \"}"],
      "json.activity-date":["{\"type\": 1, \"iso-date\": \"2024-10-21\"}","{\"type\": 2, \"iso-date\": \"2024-11-11\"}","{\"type\": 3, \"iso-date\": \"2028-03-31\"}"],
      "json.contact-info":["{\"type\": 1, \"organisation\": {\"narrative\": \"UK - Foreign, Commonwealth Development Office (FCDO)\", \"narrative.lang\": \" \"}, \"telephone\": \"+44 (0) 1355 84 3132\", \"email\": \"enquiry@fcdo.gov.uk\", \"mailing-address\": {\"narrative\": \"Public Enquiry Point, Abercrombie House, Eaglesham Road, East Kilbride, Glasgow G75 8EA\", \"narrative.lang\": \" \"}}"],
      "json.recipient-region":["{\"code\": 998, \"percentage\": 100.0}"],
      "json.sector":["{\"vocabulary\": 1, \"vocabulary-uri\": \"http://reference.iatistandard.org/codelists/Sector/\", \"code\": 12182, \"percentage\": 100.0, \"narrative\": \"Medical research\", \"narrative.lang\": \" \"}"],
      "json.policy-marker":["{\"vocabulary\": 1, \"code\": 1, \"significance\": 1, \"narrative\": \"Gender Equality\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 5, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Convention on Biological Diversity\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 6, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 7, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 8, \"significance\": 0, \"narrative\": \"Aid Targeting the Objectives of the Convention to Combat Desertification\", \"narrative.lang\": \" \"}","{\"vocabulary\": 1, \"code\": 11, \"significance\": 0, \"narrative\": \"Disability\", \"narrative.lang\": \" \"}"],
      "json.related-activity":["{\"ref\": \"GB-GOV-1-400499-401\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-402\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-403\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-404\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-405\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-406\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-407\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-408\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-409\", \"type\": 2}","{\"ref\": \"GB-GOV-1-400499-410\", \"type\": 2}"],
      "related_budget_value":[10000000,10000000,4000000,2000000,1500000,1500000,1500000,1500000,1250000,1250000,1250000,1250000,8000000,4000000,5000000,2500000,750000,750000,750000,750000,7400000,1950000,2500000,2500000,662499,662499,662499,662499,7000000,3000000,5000000,2500000,999999,999999,999999,999999,999999,999999,999999,999999,927752,499999,500000,500000,500000,500000,500000,500000,500000,5074317,750798,750798,750798,750798,454891,454891,454891,454891,1213339,437094,437094,437094,437094,328656,328656,328656,328656,79891,117248,0,4592444,566950,566950,566950,566950,289029,289029,289029,289029,422080,309717,309717,309717,309717,207583,207583,207583,207583,1397947,395484,395484,395484,395484,331863,331863,331863,331863],
      "related_budget_period_start_quarter":[4,1,4,1,2,3,4,1,2,3,4,1,4,1,4,1,2,3,4,1,4,1,4,1,2,3,4,1,4,1,4,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1],
      "related_budget_period_end_quarter":[4,1,4,1,2,3,4,1,2,3,4,1,4,1,4,1,2,3,4,1,4,1,4,1,2,3,4,1,4,1,4,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1,1,2,3,4,1,2,3,4,1],
      "related_budget_period_start_iso_date":["2024-10-01T00:00:00Z","2025-01-01T00:00:00Z","2025-10-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2024-10-01T00:00:00Z","2025-01-01T00:00:00Z","2025-10-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2024-10-01T00:00:00Z","2025-01-01T00:00:00Z","2025-10-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2024-10-01T00:00:00Z","2025-01-01T00:00:00Z","2025-10-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2025-04-01T00:00:00Z","2025-07-01T00:00:00Z","2025-10-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z","2026-01-01T00:00:00Z","2026-04-01T00:00:00Z","2026-07-01T00:00:00Z","2026-10-01T00:00:00Z","2027-01-01T00:00:00Z","2027-04-01T00:00:00Z","2027-07-01T00:00:00Z","2027-10-01T00:00:00Z","2028-01-01T00:00:00Z"],
      "related_budget_period_end_iso_date":["2024-12-31T00:00:00Z","2025-03-31T00:00:00Z","2025-12-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2024-12-31T00:00:00Z","2025-03-31T00:00:00Z","2025-12-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2024-12-31T00:00:00Z","2025-03-31T00:00:00Z","2025-12-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2024-12-31T00:00:00Z","2025-03-31T00:00:00Z","2025-12-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2025-06-30T00:00:00Z","2025-09-30T00:00:00Z","2025-12-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z","2026-03-31T00:00:00Z","2026-06-30T00:00:00Z","2026-09-30T00:00:00Z","2026-12-31T00:00:00Z","2027-03-31T00:00:00Z","2027-06-30T00:00:00Z","2027-09-30T00:00:00Z","2027-12-31T00:00:00Z","2028-03-31T00:00:00Z"],
      "id":"79b08e68-b3e4-4139-bd37-c8648d83baf9",
      "related_activity_context":"ID: GB-GOV-1-400499\nTitle: Support to Product Development Partnerships on Global Health - 2024-2028.\nDescription: Support to Product Development Partnerships through new and existing partnerships, drawing on UK and global science expertise, bringing to market vaccines, contraceptives, medicines and other tools.\n \n ID: GB-GOV-1-400499-401\nTitle: Support to Medicines for Malaria Venture to discover, develop and deliver new, effective and affordable antimalarial medicines.\nDescription: To reduce the burden of malaria in low- and middle-income countries (LMICs) by discovering, developing and delivering new, effective and affordable antimalarial medicines, which are especially needed for children and women, and to fight drug-resistant malaria.\n \n ID: GB-GOV-1-400499-402\nTitle: Develop next-generation patient-centred TB treatments to reduce disease & treatment-related stigma & quality of life impediments\nDescription: To advance the global search for highly effective, safer, shorter, and more affordable TB therapeutics by catalysing the field, convening cross-sector partnerships, and innovating in areas of discovery, development and delivery of novel TB interventions.\n \n ID: GB-GOV-1-400499-403\nTitle: Support to IVCC to develop vector control solutions to prevent mosquitoes from transmitting malaria and other diseases.\nDescription: To support the development of an effective mosquito control toolbox to protect communities against malaria and potentially other mosquito-borne diseases.\n \n ID: GB-GOV-1-400499-404\nTitle: Support to DNDi to discover, develop, and deliver treatments for the most neglected populations.\nDescription: This project aims to improve accessibility to medical products and drive innovation based on global health needs by developing an ‘end-to-end’ approach to drug R&D, from discovery and preclinical research to clinical trials and delivery, bringing new treatments to the most-neglected patients.\n \n ID: GB-GOV-1-400499-405\nTitle: Support to IVI for Vaccine Research and Development\nDescription: This component gives support to the International Vaccine Institute to support their research and development on vaccine research and development.\n \n ID: GB-GOV-1-400499-406\nTitle: Support for CBR Research and Development of SRHR Products\nDescription: The Center for Biomedical Research (CBR), a non-profit Product Development Partnership (PDP), will advance innovative products aligned with FCDO’s global health priorities: Women and girls' health, including comprehensive sexual reproductive health and rights (SRHR) and infectious diseases of poverty.\n \n ID: GB-GOV-1-400499-407\nTitle: Research and Development for Elimination of NTDs (ENDPOINT)\nDescription: Neglected Tropical Diseases (NTDs) adversely affect the health and economic prosperity of the most vulnerable in global society, yet many have the potential to be eradicated or eliminated as a public health problem. For this to be achieved, the World Health Organisation recognises that innovations in new treatment interventions, better diagnostics, and synergistic control measures to suppress the insects which spread NTDs between people are urgently required. The WHO has formulated a roadmap to NTD elimination with specific targets set by 2030. Responding to this policy initiative, ENDPOINT is a multidisciplinary international product development partnership co-ordinated by The Liverpool School of Tropical Medicine Centre for Drugs & Diagnostics.\n \n ID: GB-GOV-1-400499-408\nTitle: Support to develop PATH’s Equitable Innovations Platform (EquIP) portfolio of products\n\nDescription: Support to PATH’s proposed Equitable Innovations Platform (EquIP) product development partnership (PDP) which aims to accelerate research and facilitate market entry of new health products to save lives globally, focusing on low- and middle-income countries (LMICs).\n \n ID: GB-GOV-1-400499-409\nTitle: Support to WMP to develop technology to reduce the threat of mosquito-borne diseases.\nDescription: Development of technology offering a safe, natural, and cost-effective method to improve the mass release of adult mosquitoes that can be deployed more efficiently, safely, and over larger areas with greater speed, to reduce the threat of mosquito-borne diseases.\n \n ID: GB-GOV-1-400499-410\nTitle: Support to Kings College London CRADLE-SMART\nDescription: CRADLE-SMART: Community empoweRment Approaches to\nDevelop Local, Early Sustainable MAteRnity care with co-developed \nTechnology\n",
      "_version_":1866240371100483585
    }]
  }
}